Number of the records: 1
A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC
- A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC / Planchard D., Andrasina I. ... [et al.].
In: Onkológia. -- ISSN 1336-8176. -- Roč. 20, č. 1 (2025), s. 63-64.
karcinóm pľúc, nemalobunkový * receptory erbB * antineoplastiká imunologické * inhibítory tyrozínkináz * štúdie klinické ako téma * osimertinib * štúdia FLAURA2 * 1. línia liečby
Number of the records: 1